Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Pieris Pharmaceuticals, Inc.. (8/10/16). "Press Release: Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Second Quarter Ended June 30, 2016". Boston, MA.

Organisations Organisation Pieris Pharmaceuticals Inc. (Nasdaq: PIRS)
  Group Pieris (Group)
  Organisation 2 BVF Partners L.P. (Biotechnology Venture Fund)
Products Product PRS-080 (Anticalin hepcidin antagonist)
  Product 2 PRS-060/AZD1402 (anti-IL4Ra Anticalin, Pieris/AstraZeneca)
Persons Person Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP)
  Person 2 Deptula-Hicks, Darlene (Pieris 201509–201702 CFO before consultant to Pieris RESIGNED 2/17)

Record changed: 2021-06-10


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Pieris (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top